Stereotaxis Inc. (STXS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Stereotaxis Inc. (STXS:NYSE), powered by AI.

Current Price
$1.82
P/E Ratio
-7.6
Market Cap
166M
Sector
Healthcare
What is the Stereotaxis Inc. stock price forecast?

Stereotaxis Inc. is currently trading at $1.82. View real-time AI analysis on Alpha Lenz.

What is Stereotaxis Inc. insider trading activity?

View the latest insider trading data for Stereotaxis Inc. on Alpha Lenz.

What is Stereotaxis Inc.'s P/E ratio?

Stereotaxis Inc.'s P/E ratio is -7.6.

Stereotaxis Inc.

NYSE · STXS
$1.82-0.02(-1.09%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Stereotaxis Inc.'s future dividend policy...
Alpha Chat Insight

Stereotaxis Inc. trades at a P/E of -7.6 (undervalued) with modest ROE of -143.6%.

Ask for details

Company Overview

Stereotaxis Inc. is a cutting-edge medical technology company that specializes in robotic systems for minimally invasive surgery. The company's primary focus is on the development and commercialization of robotic navigation technologies designed to enhance the precision, safety, and efficiency of procedures within the cardiac arrhythmia treatment sector. Stereotaxis' flagship product, the Niobe Magnetic Navigation System, enables physicians to maneuver catheters with a high degree of accuracy, using magnetic fields to decrease potential complications associated with traditional manual techniques. This technology significantly impacts the healthcare sector, particularly hospitals and medical centers specializing in interventional cardiology, by improving patient outcomes and operational workflows. Based in St. Louis, Missouri, Stereotaxis plays a significant role in advancing the field of robotic surgery, contributing to the broader medical device market's growth and innovation.

CEODr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees139

Company Statistics

FY 2025

Profile

$165.54MMarket Cap
$32.38MRevenue
0.00Shares Out
139Employees

Margins

52.73%Gross
-63.49%EBITDA
-68.30%Operating
-66.85%Pre-Tax
-66.85%Net

Valuation

-7.65P/E
8.84P/B
5.11EV/Sales
-7.66EV/EBITDA
-12.02P/FCF

Growth (CAGR)

4.78%Rev 3Yr
3.99%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-43.73%ROA
-143.55%ROE
-44.68%ROIC

Financial Health

$13.42MCash & Cash Equivalents
$20.11MNet Debt
179.10%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Stereotaxis Inc. (ticker: STXS) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 139 employees. Market cap is $166M.

The current price is $1.82 with a P/E ratio of -7.65x and P/B of 8.84x.

ROE is -143.55% and operating margin is -68.30%. Annual revenue is $32M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Stereotaxis Inc. (STXS) Stock Forecast 2026 $1.82 — Price, Financials & Analyst Targets | Alpha Lenz